Segra completed the acquisition of Klonetics.

Segra, a biotechnology company and cannabis tissue culture nursery, completed the acquisition of Klonetics, a licensed cannabis nursery and cultivation company. FInancial terms were not disclosed. "The amalgamation with Klonetics marks an important milestone in our growth. By combining Klonetics' facility with Segra’s advanced tissue culture, genetics, and global sales force, we are well-positioned to accelerate our growth and service to the global cannabis industry," Jamie Blundell, Segra CEO.